Skip to main content
. 2018 Jun 20;13(6):e0197876. doi: 10.1371/journal.pone.0197876

Table 2. Patients with discordance between VWF:RCo/VWF:Ag-VWF:CB/VWF:Ag-multimeric pattern.

Patient FVIII:C(IU/dL) VWF:Ag (IU/dL) VWF:Rco
(IU/dL)
VWF:CB (IU/dL) VWF:RCo/ VWF:Ag VWF:CB/ VWF:Ag Multimeric analysis Mutation Type
C02P026F08 44 21 7.4 8.8 0.35 0.42 Smear p.Arg1315Cys* 2A/2M
C02P027F08 28 11 7.1 6.4 0.64 0.58 Smear p.Arg1315Cys* 2A/2M
C02P034F12 23 26 8.4 14 0.32 0.54 Smear p.Arg1315Cys* 2A/2M
C03P017F76 39 44 11.8 23 0.27 0.52 Smear p.Arg1374Cys* 2A/2M
C13P009F07 20 9.5 5 5.8 0.53 0.61 Smear p.Arg1315Cys* 2A/2M
C13P016F07 21 11 5 6.7 0.45 0.61 Smear p.Arg1315Cys* 2A/2M
C01P038F20 20 20 5.3 13 0.27 0.65 Smear p.Arg1315Cys* 2A/2M
C01P002F02 34 16 4.4 9.2 0.28 0.58 Smear p.Arg1374Cys* 2A/2M
C01P003F02 45 20 6.7 13 0.34 0.65 Smear p.Arg1374Cys* 2A/2M
C01P020F02 47 32 11 19 0.34 0.59 Smear p.Arg1374Cys* 2A/2M
C01P022F02 59 54 18 30 0.33 0.55 Smear p.Arg1374Cys* 2A/2M
C01P039F02 24 23 12 15 0.52 0.65 Smear p.Arg1374Cys* 2A/2M
C01P007F04 38 25 7.8 15 0.31 0.6 Smear p.Arg1374Cys* 2A/2M
C01P015F04 36 19 7.8 11 0.41 0.58 Smear p.Arg1374Cys* 2A/2M
C01P023F04 27 30 13 18 0.43 0.6 Smear p.Arg1374Cys* 2A/2M
C01P033F04 32 27 10 16 0.37 0.59 Smear p.Arg1374Cys* 2A/2M
C01P042F16 26 27 4.9 17 0.18 0.63 Smear p.Arg1374Cys* 2A/2M
C01P071F16 17 13 6.6 6.7 0.51 0.51 Smear p.Arg1374Cys* 2A/2M
C37P003F03 44 30 25 20 0.83 0.66 Smear p.Cys2491Arg 2A/2M
C30P012F07 18 32 28 19 0.88 0.59 Smear p.Arg763Ser 2A/2M y 2N
C30P013F08 53 78 31.8 34 0.41 0.43 Smear p.Arg763Ser 2A/2M y 2N
C02P047F18 30 9.3 6.4 6.1 0.69 0.66 Smear p.Pro1824His* 1 Smeary
C02P001F01 19 9.7 2.6 6 0.27 0.62 Normal p.Arg1205His* 1
C13P006F04 16 10 6 6.1 0.6 0.61 Normal p.Arg1205His* 1
C32P004F04 6.3 9.8 4 5 0.41 0.51 Normal c.2821-123A>C 1
C37P005F05 44 26 18 18 0.69 0.69 Normal p.Arg960Trp* 1
C39P019F08 30 23 12 16 0.52 0.69 Normal c.3390C>T* 1
C32P007F07 46 69 35 34 0.51 0.49 Normal p.Ile482Met 1H
C30P004F03 26 16 5.4 13 0.34 0.81 ↓HMWM p.Leu1307Pro* 2A
C30P007F03 24 13 5.9 9.9 0.45 0.76 ↓HMWM p.Leu1307Pro* 2A
C30P010F03 21 11 5.6 9.2 0.51 0.83 ↓HMWM p.Leu1307Pro* 2A
C03P007F04 30 18 6.4 15 0.36 0.83 ↓HMWM p.Arg1374His* 2A
C03P008F04 26 14 7 14 0.5 1 ↓HMWM p.Arg1374His* 2A
C30P005F04 26 22 5.8 15 0.26 0.68 Normal p.Arg1374His 2A
C30P015F04 29 31 5 14 0.16 0.45 Normal p.Arg1374His 2A
C30P016F04 26 22 5 12 0.23 0.54 Normal p.Arg1374His 2A
C30P019F04 21 26 5 12 0.19 0.46 Normal p.Arg1374His 2A
C30P020F04 45 62 5.6 27 0.09 0.43 Normal p.Arg1374His 2A
C30P021F04 33 35 5.8 17 0.19 0.49 Normal p.Arg1374His 2A
C30P022F04 25 30 5.6 14 0.19 0.47 Normal p.Arg1374His 2A
C30P024F04 19 25 5.4 14 0.22 0.56 Normal p.Arg1374His 2A
C30P025F04 25 26 4 11 0.15 0.42 Normal p.Arg1374His 2A
C30P026F04 27 33 4 18 0.12 0.55 Normal p.Arg1374His 2A
C30P031F04 21 22 4 11 0.18 0.5 Normal p.Arg1374His 2A
C30P032F04 41 57 9 29 0.16 0.51 Normal p.Arg1374His 2A
C30P034F04 21 21 5 9.8 0.24 0.47 Normal p.Arg1374His 2A
C30P036F04 30 23 5 11 0.22 0.48 Normal p.Arg1374His 2A
C39P005F03 26 13 7.1 14 0.55 1.08 ↓HMWM p.Arg1374His* 2A
C39P006F03 23 12 4.7 14 0.39 1.17 ↓HMWM p.Arg1374His* 2A
C06P021F15 31 13 5.7 13 0.44 1 ↓HMWM p.Arg1374His* 2A
C06P022F15 30 16 6.1 16 0.38 1 ↓HMWM p.Arg1374His* 2A
C39P001F02 35 18 5 17 0.28 0.94 ↓HMWM p.Arg1374His* 2A
C39P004F02 29 13 6.7 15 0.52 1.15 ↓HMWM p.Arg1374His* 2A
C39P011F06 31 17 7.7 21 0.45 1.23 ↓HMWM p.Ser1506Leu* 2A
C39P012F06 13 8.2 5 6.9 0.61 0.84 ↓HMWM p.Ser1506Leu* 2A
C42P010F10 52 69 58.5 45 0.85 0.65 ↓HMWM p.Arg1597Gln* 2A
C22P005F05 47 12 6.9 11 0.58 0.92 ↓HMWM p.Val1414Gly 2A
C07P006F02 26 17 4 12 0.24 0.71 ↓HMWM p.Asp1614Asn 2A
C02P078F07 55 34 24 21 0.71 0.62 ↓HMWM p.Arg1308Cys* 2B
C27P015F08 63 33 18.5 25 0.56 0.76 ↓HMWM p.Arg1306Trp* 2B
C14P001F01 15 9 6 7.6 0.67 0.84 ↓HMWM p.Arg1306Trp* 2B
C12P015F08 48 56 45 42 0.8 0.75 ↓HMWM p.Arg1306Gln* 2B
C35P009F04 24 23 18 16 0.78 0.69 ↓HMWM p.Arg1308Cys* 2B
C01P066F32 26 16 4 11 0.25 0.69 Normal p.Gly1415Asp* 2M
C12P020F13 67 84 55 53 0.65 0.63 Normal p.Arg1399His* 2M
C27P010F06 18 6.8 4 4.3 0.59 0.63 Normal p.Leu1382Pro* 2M
C03P023F32 21 12 4.4 7.7 0.37 0.64 Normal p.Val1409Phe 2M
C03P024F32 26 25 7.2 12 0.29 0.48 Normal p.Val1409Phe/p.Arg1399His 2M
C03P025F32 65 109 17 42 0.16 0.38 Normal p.Val1409Phe 2M
C12P023F16 213 272 186 178 0.68 0.65 Normal p.Arg1395Trp 2M
C30P027F10 34 36 16 20 0.44 0.55 Normal p.Arg1779Leu 2M
C30P028F10 19 28 13.6 16 0.49 0.57 Normal p.Arg1779Leu 2M
C44P003F02 11 16 5 11 0.31 0.69 Normal p.Gly1415Asp/Arg854Gln* 2M
C44P008F06 23 28 6.2 19 0.22 0.68 Normal p.Val1409Phe 2M
C44P009F06 60 46 10.4 32 0.23 0.69 Normal p.Val1409Phe 2M
C44P010F06 33 33 7.4 21 0.22 0.64 Normal p.Val1409Phe 2M
C03P022F25 85 88 46 48 0.52 0.55 Normal c.7082-2A>G/c.7730-177G>T* 3 carrier
C32P011F10 88 51 23.5 21 0.46 0.41 Normal p.Gln1311Ter* 3 carrier
NV 60–140 47–190 50–170 60–130 >0.7 >0.7

NV: Normal value; FVIII:C: procoagulant factor VIII; VWF:Ag: VWF antigen; VWF:RCo: VWF ristocetin cofactor activity; VWF:CB: VWF collagen binding; ↓HMWM: decreased proportion of high molecular weight multimers.

Mutations previously described are indicated in bold type.

* Multimeric pattern consistent with the mutation.